Avoid common mistakes on your manuscript.
Dear Editorwe would like to share ideas on the publication “Neuropsychiatric post-acute sequelae of COVID-19: prevalence, severity, and impact of vaccination [1].” With regard to Egyptian COVID-19 survivors, Elmazny et al. sought to ascertain the prevalence and determinants of neuropsychiatric post-acute sequelae of the virus as well as the effects of complete immunization prior to COVID-19 infection on the occurrence and severity of these manifestations [1]. In this report, fatigue was identified as the most common neuropsychiatric sequelae in 36.5% of Egyptian COVID-19 survivors, according to Elmazny et al. [1]. According to Elmazny et al., the ability of COVID-19 vaccinations to lessen the severity of various post-COVID-19 neuropsychiatric manifestations may increase public support for vaccination.
Our shared opinion is that the current data may or may not suggest that immunizations are useful in lessening the severity of some post-COVID-19 neuropsychiatric symptoms. Any potential complicating factors must be taken into consideration. It's crucial to rule out the effects of co-morbidity and any underlying immunological or gynecological conditions before moving forward with any other steps. Asymptomatic COVID-19 should also be ruled out in patients who require specialized laboratory tests because it is relatively rare [2] which will help prevent incorrect diagnoses. The body's response to a vaccine can also be influenced by the underlying genetic component [3]. On these elements, more study is required.
References
Elmazny A, Magdy R, Hussein M, Elsebaie EH, Ali SH, Abdel Fattah AM, Hassan M, Yassin A, Mahfouz NA, Elsayed RM, Fathy W, Abdel-Hamid HM, Abdelbadie M, Soliman SH (2023) Neuropsychiatric post-acute sequelae of COVID-19: prevalence, severity, and impact of vaccination. Eur Arch Psychiatry Clin Neurosci. https://doi.org/10.1007/s00406-023-01557-2
Joob B, Wiwanitkit V (2020) Letter to the Editor: Coronavirus Disease 2019 (COVID-19), Infectivity, and the Incubation Period. J Prev Med Public Health 53(2):70
Speletas M, Bakaros E, Peristeri AM, Voulgaridi I, Sarrou S, Paliatsa V, Nasika A, Tseroni M, Anagnostopoulos L, Theodoridou K, Kalala F, Theodoridou A, Mouchtouri BA, Tsiodras S, Eibel H, Hadjichristodoulou C (2022) The rs1883832 Polymorphism (CD40-1C>T) Affects the Intensity of IgA Responses after BNT162b2 Vaccination. Int J Mol Sci 23(22):14056
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors have no fund and no co conflict of interest.
Rights and permissions
About this article
Cite this article
Kleebayoon, A., Wiwanitkit, V. Correspondence: Neuropsychiatric post-acute sequelae of COVID-19. Eur Arch Psychiatry Clin Neurosci (2023). https://doi.org/10.1007/s00406-023-01586-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00406-023-01586-x